| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881222 | The Annals of Thoracic Surgery | 2009 | 8 Pages |
Abstract
This study demonstrates that TP508 decreases infarct size, improves endothelial microvascular function, and induces cell-survival signaling in the setting of ischemia-reperfusion injury. Thus, TP508 may be a useful agent to attenuate myocardial reperfusion injury.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert M. MD, Cesario MD, PhD, Richard T. PhD, Jun MD, PhD, Yuhong MD, Shu-Hua PhD, Michael P. MD, John PhD, Frank W. MD,